When does being careful become its own kind of reckless?: Precautionary principle

We carry the inventory

I have watched this cycle three times now — a crisis arrives, the action-biased demand speed, the safety architecture gets called a bottleneck, and everyone who remembers thalidomide is treated as an obstacle to progress. The crisis passes, and five years later we discover that the thing we rushed has a side effect profile nobody had time to map, and the same people who called us slow are nowhere to be found when the letters from the injured start arriving.

Thalidomide was approved in forty-six countries. Ten thousand children born with shortened or missing limbs. The drug stayed on the market five years after the first birth defect reports because the manufacturer disputed causation and regulators waited for conclusive evidence. Diethylstilbestrol, prescribed to pregnant women from 1941 to 1971, caused cancer in their daughters decades later. Tetraethyl lead poisoned the industrialized world for sixty years. Each substance had an action-biased champion who said the data looked good enough.

The action-biased calculate the cost of FDA deliberation in QALYs. Congress listened to the same math in the 1990s. The FDA Modernization Act accelerated review timelines. Then Vioxx killed an estimated 60,000 people — a drug that passed the faster review, prescribed to 80 million patients before anyone noticed the cardiovascular signal.

We do not dispute that the twenty-one days cost lives. We dispute that the correct response is dismantling the architecture that prevents the next thalidomide.

The context weighers want dynamic risk assessment. Every institution that has tried it in practice ended up captured by the fastest-moving stakeholder — which is always industry.

Where we concede ground: The fourteen months to full approval is hard to defend. We held the line past the point where holding it served the principle.

What would change our mind: A twenty-year study of expedited approvals showing equal or lower post-market safety withdrawals versus standard timelines.

Read the full synthesis: When does being careful become its own kind of reckless?